293 related articles for article (PubMed ID: 20833496)
21. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
22. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
Jeh SK; Kim SH; Kim HS; Kang BJ; Jeong SH; Yim HW; Song BJ
J Magn Reson Imaging; 2011 Jan; 33(1):102-9. PubMed ID: 21182127
[TBL] [Abstract][Full Text] [Related]
23. Diabetic fibrous mastopathy: dynamic contrast-enhanced magnetic resonance imaging findings.
Tuncbilek N; Karakas HM; Okten O
Breast J; 2004; 10(4):359-62. PubMed ID: 15239797
[TBL] [Abstract][Full Text] [Related]
24. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
25. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
26. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
27. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammography.
Vag T; Baltzer PA; Renz DM; Pfleiderer SO; Gajda M; Camara O; Kaiser WA
Clin Imaging; 2008; 32(6):438-42. PubMed ID: 19006771
[TBL] [Abstract][Full Text] [Related]
29. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
Ghanouni P; Kurian AW; Margolis D; Hartman AR; Mills MA; Plevritis SK; Ford JM; Daniel BL
Breast J; 2007; 13(3):281-6. PubMed ID: 17461903
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced breast MR imaging.
Moon M; Cornfeld D; Weinreb J
Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
[TBL] [Abstract][Full Text] [Related]
31. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
Kaiser WA
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
[TBL] [Abstract][Full Text] [Related]
32. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
34. [Magnetic resonance mammography--open questions].
Kessler M; Sittek H; Reiser M
Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):M107-15. PubMed ID: 8974887
[No Abstract] [Full Text] [Related]
35. A general dual-bolus approach for quantitative DCE-MRI.
Kershaw LE; Cheng HL
Magn Reson Imaging; 2011 Feb; 29(2):160-6. PubMed ID: 21129878
[TBL] [Abstract][Full Text] [Related]
36. Optimized density-weighted imaging for dynamic contrast-enhanced 3D-MR mammography.
Gutberlet M; Roth A; Hahn D; Köstler H
J Magn Reson Imaging; 2011 Feb; 33(2):328-39. PubMed ID: 21274974
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
38. On the selection of optimal flip angles for T1 mapping of breast tumors with dynamic contrast-enhanced magnetic resonance imaging.
Zhang JL; Koh TS
IEEE Trans Biomed Eng; 2006 Jun; 53(6):1209-14. PubMed ID: 16761851
[TBL] [Abstract][Full Text] [Related]
39. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study.
Jansen SA; Fan X; Medved M; Abe H; Shimauchi A; Yang C; Zamora M; Foxley S; Olopade OI; Karczmar GS; Newstead GM
Phys Med Biol; 2010 Oct; 55(19):N473-85. PubMed ID: 20858914
[TBL] [Abstract][Full Text] [Related]
40. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
